nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—ALB—metabolic syndrome X	0.617	1	CbGaD
Canagliflozin—UGT2B4—pericardium—metabolic syndrome X	0.0538	0.462	CbGeAlD
Canagliflozin—SLC5A2—kidney—metabolic syndrome X	0.011	0.0944	CbGeAlD
Canagliflozin—SLC5A1—cardiovascular system—metabolic syndrome X	0.00852	0.0731	CbGeAlD
Canagliflozin—SLC5A1—kidney—metabolic syndrome X	0.00834	0.0715	CbGeAlD
Canagliflozin—UGT2B4—cardiovascular system—metabolic syndrome X	0.00785	0.0673	CbGeAlD
Canagliflozin—UGT1A9—kidney—metabolic syndrome X	0.00525	0.045	CbGeAlD
Canagliflozin—UGT2B4—liver—metabolic syndrome X	0.00486	0.0416	CbGeAlD
Canagliflozin—UGT1A9—liver—metabolic syndrome X	0.00332	0.0285	CbGeAlD
Canagliflozin—ABCC2—kidney—metabolic syndrome X	0.00227	0.0195	CbGeAlD
Canagliflozin—ABCB1—blood vessel—metabolic syndrome X	0.00187	0.016	CbGeAlD
Canagliflozin—ORM1—liver—metabolic syndrome X	0.00175	0.015	CbGeAlD
Canagliflozin—ALB—liver—metabolic syndrome X	0.00153	0.0131	CbGeAlD
Canagliflozin—ABCC2—liver—metabolic syndrome X	0.00143	0.0123	CbGeAlD
Canagliflozin—CYP3A4—kidney—metabolic syndrome X	0.00115	0.00989	CbGeAlD
Canagliflozin—ABCB1—cardiovascular system—metabolic syndrome X	0.000834	0.00715	CbGeAlD
Canagliflozin—ABCB1—kidney—metabolic syndrome X	0.000816	0.007	CbGeAlD
Canagliflozin—ABCB1—adipose tissue—metabolic syndrome X	0.000735	0.00631	CbGeAlD
Canagliflozin—CYP3A4—liver—metabolic syndrome X	0.000729	0.00625	CbGeAlD
Canagliflozin—ABCB1—liver—metabolic syndrome X	0.000516	0.00442	CbGeAlD
Canagliflozin—SLC5A1—Metabolism—ALB—metabolic syndrome X	9.06e-05	0.00034	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ALB—metabolic syndrome X	9.06e-05	0.00034	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	9.02e-05	0.000339	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—APOE—metabolic syndrome X	8.93e-05	0.000335	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	8.85e-05	0.000332	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—APOA1—metabolic syndrome X	8.83e-05	0.000331	CbGpPWpGaD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—metabolic syndrome X	8.81e-05	0.000331	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—NOS3—metabolic syndrome X	8.67e-05	0.000325	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—NOS3—metabolic syndrome X	8.67e-05	0.000325	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—APOB—metabolic syndrome X	8.6e-05	0.000323	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—G6PD—metabolic syndrome X	8.53e-05	0.00032	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	8.52e-05	0.00032	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	8.41e-05	0.000316	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—HDAC3—metabolic syndrome X	8.32e-05	0.000312	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—APOA1—metabolic syndrome X	8.19e-05	0.000307	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—TGFB1—metabolic syndrome X	8.18e-05	0.000307	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GCKR—metabolic syndrome X	8.13e-05	0.000305	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—LPA—metabolic syndrome X	8.13e-05	0.000305	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IL6—metabolic syndrome X	8.13e-05	0.000305	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	8.04e-05	0.000302	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—TNF—metabolic syndrome X	8e-05	0.0003	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	7.97e-05	0.000299	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PTGS2—metabolic syndrome X	7.93e-05	0.000297	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PTGS2—metabolic syndrome X	7.93e-05	0.000297	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PLA2G6—metabolic syndrome X	7.88e-05	0.000296	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	7.82e-05	0.000294	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—APOA5—metabolic syndrome X	7.8e-05	0.000293	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PPARG—metabolic syndrome X	7.78e-05	0.000292	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—TNF—metabolic syndrome X	7.64e-05	0.000287	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—INS—metabolic syndrome X	7.63e-05	0.000286	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	7.6e-05	0.000285	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	7.57e-05	0.000284	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	7.55e-05	0.000283	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	7.42e-05	0.000279	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—FMO3—metabolic syndrome X	7.41e-05	0.000278	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	7.34e-05	0.000275	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	7.33e-05	0.000275	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	7.26e-05	0.000272	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—TRIB3—metabolic syndrome X	7.25e-05	0.000272	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—GCK—metabolic syndrome X	7.22e-05	0.000271	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	7.02e-05	0.000263	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ALB—metabolic syndrome X	6.99e-05	0.000262	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—CETP—metabolic syndrome X	6.97e-05	0.000262	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—IGF1—metabolic syndrome X	6.84e-05	0.000257	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—TGFB1—metabolic syndrome X	6.84e-05	0.000257	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—TGFB1—metabolic syndrome X	6.84e-05	0.000257	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	6.81e-05	0.000256	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	6.81e-05	0.000255	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	6.74e-05	0.000253	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—NOS3—metabolic syndrome X	6.69e-05	0.000251	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	6.63e-05	0.000249	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—MLXIPL—metabolic syndrome X	6.61e-05	0.000248	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—EPHX2—metabolic syndrome X	6.61e-05	0.000248	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—AKT1—metabolic syndrome X	6.57e-05	0.000247	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—NAMPT—metabolic syndrome X	6.5e-05	0.000244	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—SERPINE1—metabolic syndrome X	6.5e-05	0.000244	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—FMO3—metabolic syndrome X	6.5e-05	0.000244	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	6.46e-05	0.000243	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GCK—metabolic syndrome X	6.46e-05	0.000242	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—LIPC—metabolic syndrome X	6.46e-05	0.000242	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—IL6—metabolic syndrome X	6.46e-05	0.000242	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—APOC3—metabolic syndrome X	6.42e-05	0.000241	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	6.33e-05	0.000238	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CETP—metabolic syndrome X	6.23e-05	0.000234	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—G6PC2—metabolic syndrome X	6.21e-05	0.000233	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PTGS2—metabolic syndrome X	6.12e-05	0.00023	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	6.11e-05	0.000229	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—SCARB1—metabolic syndrome X	5.97e-05	0.000224	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	5.91e-05	0.000222	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	5.81e-05	0.000218	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—SREBF1—metabolic syndrome X	5.8e-05	0.000218	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—EPHX2—metabolic syndrome X	5.79e-05	0.000217	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—MLXIPL—metabolic syndrome X	5.79e-05	0.000217	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	5.72e-05	0.000215	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GOT2—metabolic syndrome X	5.64e-05	0.000212	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—HMGCR—metabolic syndrome X	5.64e-05	0.000212	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	5.62e-05	0.000211	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	5.59e-05	0.00021	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—IGF2—metabolic syndrome X	5.49e-05	0.000206	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—G6PC2—metabolic syndrome X	5.44e-05	0.000204	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	5.39e-05	0.000202	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—APOB—metabolic syndrome X	5.33e-05	0.0002	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—FABP4—metabolic syndrome X	5.28e-05	0.000198	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PLA2G4A—metabolic syndrome X	5.19e-05	0.000195	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—IL6—metabolic syndrome X	5.16e-05	0.000193	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—IL6—metabolic syndrome X	5.16e-05	0.000193	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	5.09e-05	0.000191	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ABCA1—metabolic syndrome X	5.03e-05	0.000189	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—SLC2A4—metabolic syndrome X	5.03e-05	0.000189	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—HSD11B1—metabolic syndrome X	5.01e-05	0.000188	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	4.92e-05	0.000185	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GGT1—metabolic syndrome X	4.87e-05	0.000183	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GOT1—metabolic syndrome X	4.87e-05	0.000183	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	4.85e-05	0.000182	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—CD36—metabolic syndrome X	4.84e-05	0.000182	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—AKT1—metabolic syndrome X	4.76e-05	0.000178	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—AKT1—metabolic syndrome X	4.76e-05	0.000178	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	4.72e-05	0.000177	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	4.64e-05	0.000174	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—FABP4—metabolic syndrome X	4.63e-05	0.000174	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—APOB—metabolic syndrome X	4.62e-05	0.000173	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—G6PD—metabolic syndrome X	4.46e-05	0.000168	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	4.4e-05	0.000165	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	4.39e-05	0.000165	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—HDAC3—metabolic syndrome X	4.36e-05	0.000164	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GCKR—metabolic syndrome X	4.26e-05	0.00016	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—LPA—metabolic syndrome X	4.26e-05	0.00016	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—APOA1—metabolic syndrome X	4.22e-05	0.000158	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—APOB—metabolic syndrome X	4.13e-05	0.000155	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PLA2G6—metabolic syndrome X	4.12e-05	0.000155	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—TGFB1—metabolic syndrome X	4.1e-05	0.000154	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	4.09e-05	0.000154	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—APOA5—metabolic syndrome X	4.08e-05	0.000153	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	4.04e-05	0.000152	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	4.04e-05	0.000152	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PLA2G4A—metabolic syndrome X	4.02e-05	0.000151	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—FMO3—metabolic syndrome X	4e-05	0.00015	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—AKT1—metabolic syndrome X	3.98e-05	0.000149	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—AKT1—metabolic syndrome X	3.98e-05	0.000149	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	3.97e-05	0.000149	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—LPL—metabolic syndrome X	3.94e-05	0.000148	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—G6PD—metabolic syndrome X	3.91e-05	0.000147	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	3.89e-05	0.000146	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	3.89e-05	0.000146	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	3.84e-05	0.000144	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—HDAC3—metabolic syndrome X	3.82e-05	0.000143	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—TRIB3—metabolic syndrome X	3.8e-05	0.000142	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	3.77e-05	0.000142	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CD36—metabolic syndrome X	3.75e-05	0.000141	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—LPA—metabolic syndrome X	3.73e-05	0.00014	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GCKR—metabolic syndrome X	3.73e-05	0.00014	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	3.65e-05	0.000137	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	3.61e-05	0.000136	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—APOA5—metabolic syndrome X	3.58e-05	0.000134	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	3.57e-05	0.000134	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	3.57e-05	0.000134	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—IGF1—metabolic syndrome X	3.53e-05	0.000132	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PPARA—metabolic syndrome X	3.48e-05	0.000131	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	3.41e-05	0.000128	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NAMPT—metabolic syndrome X	3.4e-05	0.000128	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	3.38e-05	0.000127	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—LIPC—metabolic syndrome X	3.38e-05	0.000127	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GCK—metabolic syndrome X	3.38e-05	0.000127	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—AGT—metabolic syndrome X	3.37e-05	0.000127	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—APOC3—metabolic syndrome X	3.36e-05	0.000126	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	3.35e-05	0.000126	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—SERPINE1—metabolic syndrome X	3.35e-05	0.000126	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—TRIB3—metabolic syndrome X	3.33e-05	0.000125	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—APOE—metabolic syndrome X	3.31e-05	0.000124	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—APOA1—metabolic syndrome X	3.27e-05	0.000123	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CETP—metabolic syndrome X	3.26e-05	0.000122	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	3.2e-05	0.00012	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—NOS3—metabolic syndrome X	3.2e-05	0.00012	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SCARB1—metabolic syndrome X	3.13e-05	0.000117	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—AKT1—metabolic syndrome X	3.08e-05	0.000115	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SREBF1—metabolic syndrome X	3.03e-05	0.000114	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NAMPT—metabolic syndrome X	2.98e-05	0.000112	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GCK—metabolic syndrome X	2.96e-05	0.000111	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—LIPC—metabolic syndrome X	2.96e-05	0.000111	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—HMGCR—metabolic syndrome X	2.95e-05	0.000111	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GOT2—metabolic syndrome X	2.95e-05	0.000111	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—APOC3—metabolic syndrome X	2.95e-05	0.000111	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PPARG—metabolic syndrome X	2.88e-05	0.000108	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CETP—metabolic syndrome X	2.86e-05	0.000107	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—FABP4—metabolic syndrome X	2.85e-05	0.000107	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	2.85e-05	0.000107	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—INS—metabolic syndrome X	2.82e-05	0.000106	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	2.81e-05	0.000105	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SCARB1—metabolic syndrome X	2.74e-05	0.000103	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	2.7e-05	0.000101	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	2.66e-05	9.99e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SREBF1—metabolic syndrome X	2.66e-05	9.98e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ABCA1—metabolic syndrome X	2.63e-05	9.87e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SLC2A4—metabolic syndrome X	2.63e-05	9.87e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ALB—metabolic syndrome X	2.59e-05	9.71e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—HMGCR—metabolic syndrome X	2.59e-05	9.71e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GOT2—metabolic syndrome X	2.59e-05	9.71e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GGT1—metabolic syndrome X	2.55e-05	9.56e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GOT1—metabolic syndrome X	2.55e-05	9.56e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	2.54e-05	9.52e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—NOS3—metabolic syndrome X	2.48e-05	9.29e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—G6PD—metabolic syndrome X	2.41e-05	9.04e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	2.35e-05	8.83e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ABCA1—metabolic syndrome X	2.31e-05	8.65e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	2.31e-05	8.65e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GCKR—metabolic syndrome X	2.3e-05	8.63e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—LPA—metabolic syndrome X	2.3e-05	8.63e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PTGS2—metabolic syndrome X	2.26e-05	8.5e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GGT1—metabolic syndrome X	2.23e-05	8.38e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GOT1—metabolic syndrome X	2.23e-05	8.38e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	2.23e-05	8.36e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—APOA5—metabolic syndrome X	2.2e-05	8.27e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—APOB—metabolic syndrome X	2.16e-05	8.11e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—TGFB1—metabolic syndrome X	2.11e-05	7.93e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PLA2G4A—metabolic syndrome X	2.1e-05	7.89e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—LPL—metabolic syndrome X	2.06e-05	7.75e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	2.05e-05	7.69e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CD36—metabolic syndrome X	1.96e-05	7.36e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—APOB—metabolic syndrome X	1.89e-05	7.11e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	1.84e-05	6.92e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.84e-05	6.9e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.83e-05	6.85e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.83e-05	6.85e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PPARA—metabolic syndrome X	1.82e-05	6.84e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.81e-05	6.81e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—LPL—metabolic syndrome X	1.81e-05	6.79e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—AGT—metabolic syndrome X	1.77e-05	6.63e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CETP—metabolic syndrome X	1.76e-05	6.61e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—APOE—metabolic syndrome X	1.73e-05	6.49e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CD36—metabolic syndrome X	1.72e-05	6.45e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—APOA1—metabolic syndrome X	1.71e-05	6.42e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	1.69e-05	6.33e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	1.64e-05	6.15e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PPARA—metabolic syndrome X	1.6e-05	6e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GOT2—metabolic syndrome X	1.59e-05	5.98e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	1.59e-05	5.98e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—AGT—metabolic syndrome X	1.55e-05	5.81e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—APOE—metabolic syndrome X	1.52e-05	5.69e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PPARG—metabolic syndrome X	1.51e-05	5.66e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—APOA1—metabolic syndrome X	1.5e-05	5.63e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—INS—metabolic syndrome X	1.48e-05	5.55e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—AKT1—metabolic syndrome X	1.47e-05	5.52e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	1.42e-05	5.33e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	1.42e-05	5.33e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GGT1—metabolic syndrome X	1.38e-05	5.16e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GOT1—metabolic syndrome X	1.38e-05	5.16e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PPARG—metabolic syndrome X	1.32e-05	4.96e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NOS3—metabolic syndrome X	1.3e-05	4.87e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—INS—metabolic syndrome X	1.3e-05	4.86e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ALB—metabolic syndrome X	1.19e-05	4.46e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PTGS2—metabolic syndrome X	1.19e-05	4.45e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—APOB—metabolic syndrome X	1.17e-05	4.38e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—AKT1—metabolic syndrome X	1.14e-05	4.27e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NOS3—metabolic syndrome X	1.14e-05	4.26e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	1.14e-05	4.26e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—LPL—metabolic syndrome X	1.11e-05	4.18e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CD36—metabolic syndrome X	1.06e-05	3.97e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PTGS2—metabolic syndrome X	1.04e-05	3.9e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PPARA—metabolic syndrome X	9.84e-06	3.69e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—AGT—metabolic syndrome X	9.53e-06	3.58e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—APOE—metabolic syndrome X	9.34e-06	3.51e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—APOA1—metabolic syndrome X	9.23e-06	3.47e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PPARG—metabolic syndrome X	8.14e-06	3.05e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—INS—metabolic syndrome X	7.98e-06	2.99e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ALB—metabolic syndrome X	7.32e-06	2.75e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NOS3—metabolic syndrome X	7e-06	2.63e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	6.4e-06	2.4e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—AKT1—metabolic syndrome X	5.96e-06	2.24e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—AKT1—metabolic syndrome X	5.22e-06	1.96e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—AKT1—metabolic syndrome X	3.22e-06	1.21e-05	CbGpPWpGaD
